Senators propose settlement limits on generic-drug lawsuits

Merril Hirsh, partner at the law firm Ross, Dixon and Bell, testifies at a Senate Judiciary Committee hearing about competition between generic and brand name drugs Wednesday in Washington. A proposal in the U.S. Senate would bar brand-name drug makers from paying would-be generic rivals to settle patent lawsuits, a process that critics say delays ...

Enter your user name and password in the fields above to gain access to the subscriber content on this site. Need a subscription? Click here.
Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time.
If you feel your login credentials are being used by a second party, contact customer service at 877-615-9536 for assistance in changing your password.

Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.

Forgot your password?

MLM Counties News. Notices. Need-to-know Information.

Senators propose settlement limits on generic-drug lawsuits

Leave a Reply